EQS-AFR: Dermapharm Holding SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements


Werte in diesem Artikel
Aktien

45.30 EUR 0.00 EUR 0.0 %

EQS Preliminary announcement financial reports: Dermapharm Holding SE / Preliminary announcement on the disclosure of financial statements
Dermapharm Holding SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

05.11.2025 / 13:48 CET/CEST
Preliminary announcement of the publication of quarterly reports and quarterly/interim statements transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Werbung


Dermapharm Holding SE hereby announces that the following financial reports shall be disclosed:

Report Type: Quarterly/ Interim statement within the 2nd half-year

Language: German
Date of disclosure: November 13, 2025
Address: https://ir.dermapharm.de/de/investor-relations/finanzberichte-praesentationen/

Language: English
Date of disclosure: November 13, 2025
Address: https://ir.dermapharm.de/en/investor-relations/financial-reports-presentations/


05.11.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: Dermapharm Holding SE
Lil-Dagover-Ring 7
82031 Grünwald
Germany
Internet: ir.dermapharm.de

 
End of News EQS News Service

Werbung

2224346  05.11.2025 CET/CEST

Aktuelle Dermapharm Aktie News

Werbung

Dermapharm Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Dermapharm nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
27.05.26 Dermapharm Hold Jefferies & Company Inc.
14.05.26 Dermapharm Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
31.03.26 Dermapharm Hold Jefferies & Company Inc.
10.03.26 Dermapharm Hold Jefferies & Company Inc.
10.03.26 Dermapharm Hold Jefferies & Company Inc.